of the glutamatergic
system plays an important role in the pathophysiology of multiple sclerosis (MS). Apart from
Isaeva, A.,
Averyanov, S.,
Iskhakov, I.,
Gulyaeva, O.,
Gileva, O.,
Kiniabaev, T. (2020) as part of complex
therapy, while in the control group (22 patients) the Cholisal gel was used. The data
Yagudin, T.,
Zhao, Y.,
Gao, H.,
Zhang, Y.,
Yang, Y.,
Zhang, X.,
Ma, W.,
Daba, T.M.,
Ishmetov, V.,
Kang, K.,
Yang, B.,
Pan, Z. (2020)
infarction in order to facilitate the development of novel
therapy. Inhibitor of apoptosis